In response to the worldwide pandemic, Viramed Biotech Ag is proud to announce a multiplex type immunoassay for the detection of antibodies to the SARS-CoV-2 Virus.
While still unavailable in the United States while waiting for FDA Emergency Use Authorization, the Viramed SARS-CoV-2 ViraChip® assays are being used in Europe under the CE mark.
The Viramed SARS-CoV-2 ViraChip® IgG and IgA test kits provide information currently unavailable to the clinician or research scientist. With quantifican of three different antibodies present in a patient sample, the Viramed SARS-CoV-2 ViraChip® gives the user a better picture of the state of the disease in the patient.
Possible uses include tracking antibody response in the general population as well as measuring response to future vaccination.
If you are having issues with this product please click HERE to notify the manufacture and report on adverse events.
V-UVNAKI Universal Anti-Hu IgA Conjugate
V-UVNGKI Universal Anti-Hu IgG Conjugate
V-UVNMKI Universal Anti-Hu IgM Conjugate V-UVNUWP Immunoblot Wash Solution Concentrate
V-UVNUMP Immunoblot Wash Powder V-UVNUCS Immunoblot Substrate Solution
V-UVNUIG 50 well Black trays (Pack of 10)
ViraCam (FDA registered)
ViraChip Reader (FDA registered)
Beeblot 50 Immunoblot Processor (FDA registered)
Gemini Processor (FDA registered)